Vaxcyte Total Non-Operating Income/Expense 2019-2024 | PCVX

Vaxcyte total non-operating income/expense for the twelve months ending September 30, 2024 was $0.096B, a 65.01% increase year-over-year.

  • Vaxcyte annual total non-operating income/expense for 2023 was $0.066B, a 649.91% increase from 2022.
  • Vaxcyte annual total non-operating income/expense for 2022 was $0.009B, a 144.11% increase from 2021.
  • Vaxcyte annual total non-operating income/expense for 2021 was $0.004B, a 887.09% increase from 2020.

Vaxcyte Total Non-Operating Income/Expense 2019-2024 | PCVX

  • Vaxcyte annual total non-operating income/expense for 2023 was $0.066B, a 649.91% increase from 2022.
  • Vaxcyte annual total non-operating income/expense for 2022 was $0.009B, a 144.11% increase from 2021.
  • Vaxcyte annual total non-operating income/expense for 2021 was $0.004B, a 887.09% increase from 2020.